Pandemic Timeline

Uncategorized

Dr. McCullough publishes a spike protein detox

“People who took the vaccines for the first time took an injection of foreign genetic material that produced spike protein in their body for an uncontrolled duration [of] time and quantity,” says  Dr. Peter McCullough, who adds “Many of you still have the spike protein in your cells and your tissues.” “Every study that’s looked at this has actually identified this central issue. The human body does not seem to have enzymes that can break down this protein like it could any other natural protein and have us get rid of it.”

However, Dr. McCullough explains that there is a detoxification protocol that allows individuals to proactively address the issue head-on by using three natural substances, nattokinase, bromelain, and curcumin, “to help the body clear this very dangerous protein from [their] cells and tissues.”

”Although the protocol has not yet been scientifically validated through double-blind, randomized, placebo-controlled trials, Dr. McCullough argued that clinical observations indicate a positive impact.

— Patricia Harrity

The majority of the global population has contracted COVID-19 and/or taken one of the many COVID-19 vaccines. As a result, the injurious SARS-CoV-2 spike protein has been an antigenic exposure to most in the world. Provided the infection was treated early and limited to the nasopharynx without invasive disease, the infection was self-limited without sequelae. Mucosal immunity with IgA, T-cells, B-cells, and natural killer cells handles the coronavirus and defends the body against systemic illness. However, in the setting of invasive disease with COVID-19 pneumonia, viremia, cytokine storm, thrombosis, and end-organ injury, there is evidence of widespread residual replicating SARS-CoV-2 spike protein in tissues for months, and the S1 segment within CD16 monocytes for more than one year.

Repeated administrations of COVID-19 vaccines, particularly the mRNA or adenoviral DNA products, deliver the genetic code for the spike protein, which is produced by a wide array of cells in tissues, resulting in an uncontrolled duration and cumulative doses of spike protein. The rise in IgG against the spike protein is many fold greater after vaccination than from the natural infection. This is a proxy for considerably greater exposure to the spike protein after immunization than after infection. Anti-spike IgG levels are associated with post-COVID-19 symptoms. Yonker et al. have recently shown that some individuals do not develop neutralizing antibodies against the spike protein, and as a result develop organ injury, particularly myocarditis in children and young adults. Free circulating soluble and extracellular vesicle-linked spike protein is associated with persistent symptoms.

The spike protein is responsible for the pathogenicity of the SARS-CoV-2 infection and drives the development of adverse events, injuries, disabilities, and death after vaccination through immunologic and thrombotic mechanisms. The spike protein has been found in the brain, heart, liver, kidneys, ovaries, testicles and other vital organs at autopsy in cases of death after vaccination. In the case of vaccine-induced thrombotic injury, the spike protein has been found within the blood clot itself.

Thus, there is strong rationale for considering residual SARS-CoV-2 spike protein as a treatment target in post COVID-19 and vaccine injury syndromes. The spike protein participates directly in pathophysiology, incites inflammation, and propels thrombosis. Thus, overlapping coverage for these domains would be desirable in a combination approach. While specific syndromes (cardiovascular, neurological, endocrine, thrombotic, immunological) will require additional therapies, we will focus the remaining discussion on degrading the spike protein and antagonizing its effects in tissues and organs.

— McCullough, Procter, Wynn

Sources:

Comments are closed.